ITALY: Tildrakizumab was found to be beneficial for up to 36 weeks in treating moderate-to-severe plaque psoriasis, according to a new study published in the Journal of the European Academy of.
WEDNESDAY, Sept. 21, 2022 (HealthDay News) Benign prostatic hyperplasia (BPH) surgery can impact sexual function, mainly involving ejaculatory function, according to a systematic review and meta-analysis recently published in European Urology Focus. Celeste Manfredi, M.D., from the University of Campania "Luigi Vanvitelli" in Naples, Italy, and colleagues conducted a systematic literature review to assess
WEDNESDAY, Sept. 21, 2022 (HealthDay News) Benign prostatic hyperplasia (BPH) surgery can impact sexual function, mainly involving ejaculatory function, according to a systematic review and meta-analysis recently published in